Literature DB >> 30748035

Activated NK cells kill hepatic stellate cells via p38/PI3K signaling in a TRAIL-involved degranulation manner.

Tianyang Li1,2, Yang Yang1, Hongxiao Song1, Haijun Li1, An Cui1, Yanhou Liu1, Lishan Su1,3, Ian Nicholas Crispe1,4, Zhengkun Tu1.   

Abstract

NK cells are important in regulating hepatic fibrosis via their cytotoxic killing of hepatic stellate cells (HSCs). NK cells are activated by both cytokines such as IL-12 and IL-18, and innate immune stimuli such as ligation of TLRs. The secretion of IL-18 depends upon activation of the inflammasome, whereas TLRs are stimulated by microbial products. In the case of NK cells, IL-18 acts synergistically with stimulation of TLR3 to cause cell activation and cytotoxic function. In the present study, we activated NK cells to kill HSCs via IL-18 and TLR3 ligand stimulation, and dissected the signaling pathways or molecules critical for such activation or killing. We find that such activation depends on signaling via the p38/PI3K/AKT pathway, and that the activated NK cells mediate HSC death in a TRAIL-involved mechanism. As liver fibrosis is a major global health problem with no good solution, these results emphasize that the p38/PI3K/AKT pathway in NK cells may be a novel drug target to promote fibrosis regression. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  IL 18; TLR3; TRAIL; p38 MAPK

Mesh:

Substances:

Year:  2019        PMID: 30748035     DOI: 10.1002/JLB.2A0118-031RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  16 in total

Review 1.  The antifibrotic role of natural killer cells in liver fibrosis.

Authors:  Yuan Wei; Wang Bingyu; Yang Lei; Yuan Xingxing
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 2.  Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease.

Authors:  Carmelo Luci; Elodie Vieira; Thibaut Perchet; Philippe Gual; Rachel Golub
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

3.  Functional Inhibition of Natural Killer Cells in a BALB/c Mouse Model of Liver Fibrosis Induced by Schistosoma japonicum Infection.

Authors:  Yuan Hu; Xiaoling Wang; Yuhuan Wei; Hua Liu; Jing Zhang; Yujuan Shen; Jianping Cao
Journal:  Front Cell Infect Microbiol       Date:  2020-11-19       Impact factor: 5.293

Review 4.  Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma.

Authors:  Moritz Peiseler; Frank Tacke
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

Review 5.  Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression.

Authors:  Alessandra Caligiuri; Alessandra Gentilini; Mirella Pastore; Stefano Gitto; Fabio Marra
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

6.  Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells.

Authors:  Qiu-Ju Han; Yong-Liang Mu; Hua-Jun Zhao; Rong-Rong Zhao; Quan-Juan Guo; Yu-Hang Su; Jian Zhang
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

Review 7.  The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression.

Authors:  Dishen Chen; Thanh H Le; Haleh Shahidipour; Scott A Read; Golo Ahlenstiel
Journal:  Cells       Date:  2019-10-27       Impact factor: 6.600

8.  Long noncoding RNA TANCR promotes γδ T cells activation by regulating TRAIL expression in cis.

Authors:  Chuan Yang; Ting Feng; Fang Lin; Tinxiang Gong; Shuo Yang; Yuhong Tao; Hong Li
Journal:  Cell Biosci       Date:  2020-02-12       Impact factor: 7.133

Review 9.  Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease.

Authors:  María Luz Martínez-Chantar; Teresa C Delgado; Naiara Beraza
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

Review 10.  Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System.

Authors:  Pietro Torre; Benedetta Maria Motta; Roberta Sciorio; Mario Masarone; Marcello Persico
Journal:  Front Med (Lausanne)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.